Metformin and HER2-positive breast cancer: Mechanisms and therapeutic implications
<p>Due to the strong association between diabetes and cancer incidents, several anti-diabetic drugs, including metformin, have been examined for their anticancer activity. Metformin is a biguanide antihyperglycemic agent used as a first-line drug for type II diabetes mellitus. It exhibits anti...
Saved in:
| Main Author: | Sara S Bashraheel (17807612) (author) |
|---|---|
| Other Authors: | Hadeel Kheraldine (14231609) (author), Sarah Khalaf (16555642) (author), Ala-Eddin Al Moustafa (5472368) (author) |
| Published: |
2023
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neratinib and metformin: A novel therapeutic approach against HER2-Positive Breast Cancer
by: Kheraldine, Hadeel
Published: (2025) -
Substantial cell apoptosis provoked by naked PAMAM dendrimers in HER2-positive human breast cancer via JNK and ERK1/ERK2 signalling pathways
by: Hadeel, Kheraldine
Published: (2021) -
Gene Expression and miRNAs Profiling: Function and Regulation in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
by: Rasha M. Sareyeldin (18131371)
Published: (2019) -
Substantial cell apoptosis provoked by naked PAMAM dendrimers in HER2-positive human breast cancer via JNK and ERK1/ERK2 signalling pathways
by: Hadeel Kheraldine (14231609)
Published: (2021) -
Targeting HER2-positive breast cancer cells by a combination of dasatinib and BMS-202: Insight into the molecular pathways
by: Hadeel Kheraldine (14231609)
Published: (2024)